SecBot SecBot
8-K ·Filed Aug 13, 2026

PULM

Pulmatrix, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed3mo ago SEC0001493152-26-037592
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

The stock is trading as a merger-arbitrage vehicle with no standalone operating value. Monitor for the closing of the Eos SENOLYTIX merger, which is the sole catalyst. The S-3 shelf registration for resale of shares by the Eos affiliate adds potential overhang post-merger.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.51
T+0 close · Aug 13, 2026 · via day close
Latest settled
−8.61%
T+60 · $1.38
Vs SPY
−3.13%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $1.51entry
  2. T+1 · 3mo ago +1.99%α +2.18% · $1.54
  3. T+5 · 3mo ago −0.66%α +1.30% · $1.50
  4. T+20 · 2mo ago −6.62%α −4.88% · $1.41
  5. T+60 · 11d ago −8.61%α −3.13% · $1.38

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Pulmatrix reported Q2 2026 financial results, showing a net loss of $1.036M ($0.29/share) compared to a $1.549M loss ($0.42/share) in Q2 2025, driven by reduced G&A expenses. The company has no revenue and is a pre-reverse-merger shell, with cash burn reducing its cash position to $2.2M (plus $0.7M restricted). The filing is a procedural update on the pending merger with Eos SENOLYTIX, which is expected to close in Q3 2026, and the company continues to operate as a going concern only through that closing.

Key Financial Metrics

EPS
−$0.29
Revenue
$0.00
est $0.00
Rating
in line

Key Facts

  • Net loss for Q2 2026 was $1.036M, improved from $1.549M in Q2 2025.
  • Cash and cash equivalents fell to $2.2M at June 30, 2026, from $4.1M at December 31, 2025.
  • The company has no revenue and all clinical development is on hold.
  • The merger with Eos SENOLYTIX is expected to close in Q3 2026; an S-4 registration statement has been filed.
  • Financial statements are prepared on a going-concern basis, with cash sufficient only through the anticipated merger close.

Financial Impact

Cash burn of ~$1.9M in H1 2026; no revenue; merger-dependent solvency

cashnet lossoperating expenses

Risk Factors

  • Merger fails to close, leading to cash depletion and potential bankruptcy.
  • Post-merger dilution: current PULM stockholders will own only ~6% of the combined entity.
  • S-3 registration enables immediate selling by the Eos affiliate post-merger, creating overhang.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-037592
Document: form8-k.htm0001493152-26-037592
Document: 0001493152-26-037592-index-headers.html0001493152-26-037592
Document: 0001493152-26-037592-index.html0001493152-26-037592
Document: 0001493152-26-037592.txt0001493152-26-037592
8-K Data (Synthetic)0001493152-26-037592

Track record

21 reports on PULM

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +15.29% at T+60 after the Aug 7, 2026 report. 6 of 8 went positive at some point.

Filters
  1. Nov 9, 20267d ago 425 Neutral 3/10 Entry $1.36 to $1.33 Now $1.33 −1.85% ▼ −1.84% −0.15% vs SPY
  2. Oct 30, 202617d ago 425 Neutral 3/10 Entry $1.40 to $1.38 Now $1.33 −5.00% ▼ −1.43% +1.27% vs SPY
  3. Oct 23, 202625d ago EFFECT Bearish 5/10 Entry $1.48 to $1.40 Now $1.33 +10.14% ▲ +5.41% +4.85% vs SPY
  4. Oct 22, 202625d ago 425 Neutral 4/10 Entry $1.42 to $1.41 Now $1.33 −6.34% ▼ −0.70% −1.41% vs SPY
  5. Oct 13, 20264w ago 425 Neutral 4/10 Entry $1.38 to $1.43 Now $1.33 −3.62% ▲ +3.62% +4.77% vs SPY
  6. Oct 7, 20265w ago DEFA14A Neutral 2/10 Entry $1.53 to $1.41 Now $1.33 −12.91% ▼ −7.67% −7.39% vs SPY
  7. Oct 2, 20266w ago S-3/A Bearish 5/10 Entry $1.48 to $1.43 Now $1.33 +10.14% ▲ +3.38% +3.80% vs SPY
  8. Sep 28, 20267w ago EFFECT Bearish 5/10 Entry $1.59 to $1.48 Now $1.33 +16.35% ▲ +6.92% +8.12% vs SPY
  9. Sep 25, 20267w ago DEFM14A Bearish 6/10 Entry $1.59 to $1.48 Now $1.33 +16.35% ▲ +6.92% +8.12% vs SPY
  10. Sep 23, 20267w ago S-4/A Neutral 2/10 Entry $1.67 to $1.54 Now $1.33 −20.36% ▼ −7.78% −7.37% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026